First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer ...

Israel Prize winner Prof. Michal Schwartz says her team's work fighting Alzheimer's can lead to treatments that boost immune ...

People in the United States are living longer and with that comes increased rates of dementia. Dr. Josef Coresh, with NYU ...

Natural treatment options for hypothyroidism ... naturally increase thyroid function, but this may not work for everyone. In some cases, it can even cause a harmful effect called thyrotoxicosis ...

Chronic stress weakens brain function and raises dementia risk. Discover how stress management can protect your mind.

During the winter months, it is crucial to be extra mindful of loved ones with Alzheimer's and dementia. According to the ...

It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ...

Biogen and Sangamo have begun a collaboration to develop gene regulation therapies for neurological diseases including Parkinson’s and Alzheimer’s in a collaboration worth more than $2.7 billion.

On track to report data from Phase 1 clinical trial evaluating VG-3927 for Alzheimer’s disease in 1Q 2025, providing critical insights into treatment ... in ILLUMINATE natural history study ...

Amyloid-related imaging abnormalities are the most impactful adverse effect of anti-amyloid-β immunotherapies. Here, the authors review the detection, underlying mechanisms and clinical ...

Tardive dyskinesia is a drug-induced neurological disorder characterized by involuntary movements of the face and body. The ...